875 related articles for article (PubMed ID: 7496598)
21. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
Isabel Zhu Y; Fitzpatrick JE
J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium.
Sheu LF; Lee WC; Lee HS; Kao WY; Chen A
J Pathol; 2005 Oct; 207(2):216-23. PubMed ID: 16021677
[TBL] [Abstract][Full Text] [Related]
23. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ.
King R; Googe PB; Page RN; Mihm MC
Mod Pathol; 2005 Aug; 18(8):1043-7. PubMed ID: 15803191
[TBL] [Abstract][Full Text] [Related]
24. Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis.
Lefevre G; Glotin AL; Calipel A; Mouriaux F; Tran T; Kherrouche Z; Maurage CA; Auclair C; Mascarelli F
J Biol Chem; 2004 Jul; 279(30):31769-79. PubMed ID: 15145934
[TBL] [Abstract][Full Text] [Related]
25. Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines.
Hassan S; Kinoshita Y; Kawanami C; Kishi K; Matsushima Y; Ohashi A; Funasaka Y; Okada A; Maekawa T; He-Yao W; Chiba T
Dig Dis Sci; 1998 Jan; 43(1):8-14. PubMed ID: 9508539
[TBL] [Abstract][Full Text] [Related]
26. Melanocytes express 3G5 surface antigen.
Fiedler E; Nayak RC; Marsch WCh; Helmbold P
Am J Dermatopathol; 2004 Jun; 26(3):200-4. PubMed ID: 15166506
[TBL] [Abstract][Full Text] [Related]
27. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
28. The expression of stem cell factor and c-kit receptor in human asthmatic airways.
Al-Muhsen SZ; Shablovsky G; Olivenstein R; Mazer B; Hamid Q
Clin Exp Allergy; 2004 Jun; 34(6):911-6. PubMed ID: 15196279
[TBL] [Abstract][Full Text] [Related]
29. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
30. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression.
Reed JA; McNutt NS; Bogdany JK; Albino AP
J Cutan Pathol; 1996 Dec; 23(6):495-505. PubMed ID: 9001979
[TBL] [Abstract][Full Text] [Related]
31. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
32. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.
Inoue M; Kyo S; Fujita M; Enomoto T; Kondoh G
Cancer Res; 1994 Jun; 54(11):3049-53. PubMed ID: 7514496
[TBL] [Abstract][Full Text] [Related]
34. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical characterization of Spitz's nevus: differentiation from common melanocytic nevus, dysplastic melanocytic nevus and malignant melanoma.
Takahashi H; Maeda K; Maeda K; Akutsu Y; Horikoshi T; Jimbow K
J Dermatol; 1987 Dec; 14(6):533-41. PubMed ID: 3329652
[No Abstract] [Full Text] [Related]
36. Melan-A positive dermal cells in malignant melanoma in situ.
Danga ME; Yaar R; Bhawan J
J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
[TBL] [Abstract][Full Text] [Related]
37. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
38. Removal of stem cell factor or addition of monoclonal anti-c-KIT antibody induces apoptosis in murine melanocyte precursors.
Ito M; Kawa Y; Ono H; Okura M; Baba T; Kubota Y; Nishikawa SI; Mizoguchi M
J Invest Dermatol; 1999 May; 112(5):796-801. PubMed ID: 10233774
[TBL] [Abstract][Full Text] [Related]
39. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
40. Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas.
Pietsch T; Nicotra MR; Fraioli R; Wolf HK; Mottolese M; Natali PG
Int J Cancer; 1998 Jan; 75(2):171-5. PubMed ID: 9462703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
